Trieu Vuong bought OTLC

July 10, 2025 · Form 4 insider transaction

Trieu Vuong bought 104,000 shares of Oncotelic Therapeutics, Inc. at $0.01 per share, a transaction worth $520.00. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.